These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 3236941)
1. 5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema. Gionchetti P; Belluzzi A; Campieri M; Torresan F; Tabanelli GM; Brignola C; Miglioli M; Barbara L Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):667-9. PubMed ID: 3236941 [TBL] [Abstract][Full Text] [Related]
2. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: long-term results. Guarino J; Chatzinoff M; Berk T; Friedman LS Am J Gastroenterol; 1987 Aug; 82(8):732-7. PubMed ID: 3496786 [TBL] [Abstract][Full Text] [Related]
3. 5-Aminosalicylic acid enemas in patients with active ulcerative colitis. Influence of acidity on the kinetic pattern. Bondesen S; Nielsen OH; Jacobsen O; Rasmussen SN; Hansen SH; Halskov S; Binder V; Hvidberg EF Scand J Gastroenterol; 1984 Jul; 19(5):677-82. PubMed ID: 6382570 [TBL] [Abstract][Full Text] [Related]
4. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis. Andreoli A; Spinella S; Levenstein S; Prantera C Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759 [TBL] [Abstract][Full Text] [Related]
5. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial. Friedman LS; Richter JM; Kirkham SE; DeMonaco HJ; May RJ Am J Gastroenterol; 1986 Jun; 81(6):412-8. PubMed ID: 3518408 [TBL] [Abstract][Full Text] [Related]
6. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas. Barber GB; Lee DE; Antonioli DA; Peppercorn MA Am J Gastroenterol; 1985 Aug; 80(8):612-4. PubMed ID: 2862789 [TBL] [Abstract][Full Text] [Related]
7. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study. d'Albasio G; Pacini F; Camarri E; Messori A; Trallori G; Bonanomi AG; Bardazzi G; Milla M; Ferrero S; Biagini M; Quaranta S; Amorosi A Am J Gastroenterol; 1997 Jul; 92(7):1143-7. PubMed ID: 9219787 [TBL] [Abstract][Full Text] [Related]
8. Combined therapy with 5-aminosalicylic tablets and enemas for maintaining remission in ulcerative colitis. d'Albasio G; Trallori G; Gavazzi O; Bardazzi G; Vannozzi G; Frittelli G; Cini E; Falai T; Varini C; Morettini A Ital J Gastroenterol; 1991 Jan; 23(1):12-4. PubMed ID: 1747494 [TBL] [Abstract][Full Text] [Related]
9. Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission. Ewe K; Becker K; Ueberschaer B Z Gastroenterol; 1996 Apr; 34(4):225-9. PubMed ID: 8686349 [TBL] [Abstract][Full Text] [Related]
10. Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion. Campieri M; Lanfranchi GA; Boschi S; Brignola C; Bazzocchi G; Gionchetti P; Minguzzi MR; Belluzzi A; Labò G Gut; 1985 Apr; 26(4):400-5. PubMed ID: 3979912 [TBL] [Abstract][Full Text] [Related]
11. Steady-state pharmacokinetics of a new 4-gram 5-aminosalicylic acid retention enema in patients with ulcerative colitis in remission. Almer S; Norlander B; Ström M; Osterwald H Scand J Gastroenterol; 1991 Mar; 26(3):327-35. PubMed ID: 1853156 [TBL] [Abstract][Full Text] [Related]
12. Topical salicylate therapy (4-ASA and 5-ASA enemas). Ginsberg AL Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990 [TBL] [Abstract][Full Text] [Related]
13. Distribution of mesalamine enemas in patients with active distal ulcerative colitis. Chapman NJ; Brown ML; Phillips SF; Tremaine WJ; Schroeder KW; Dewanjee MK; Zinsmeister AR Mayo Clin Proc; 1992 Mar; 67(3):245-8. PubMed ID: 1545592 [TBL] [Abstract][Full Text] [Related]
14. Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis. Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tampieri M; Iannone P; Miglioli M; Barbara L Gut; 1991 Aug; 32(8):929-31. PubMed ID: 1885075 [TBL] [Abstract][Full Text] [Related]
16. Low Pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis: a randomized, double-blind study. Bianchi Porro G; Ardizzone S; Petrillo M; Fasoli A; Molteni P; Imbesi V Am J Gastroenterol; 1995 May; 90(5):736-9. PubMed ID: 7733079 [TBL] [Abstract][Full Text] [Related]
17. Five-aminosalicylic acid enemas in treatment of ulcerative colitis. Fedotin MS Mo Med; 1985 Jun; 82(6):301-3. PubMed ID: 4010664 [No Abstract] [Full Text] [Related]
18. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group. Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559 [TBL] [Abstract][Full Text] [Related]
19. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis. Marshall JK; Irvine EJ Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961 [TBL] [Abstract][Full Text] [Related]